Newstral
Article
Iinnovations-report.com on 2015-08-31 14:45
MACC1 Gene Is an Independent Prognostic Biomarker for Survival in Klatskin Tumor Patients
Related news
- New treatment helps extend survival for brain tumor patientsreviewjournal.com
- TBreast Cancer Survivor Pushes for Biomarker Testing for Medicaid Patientstoday.uconn.edu
- ISuicide gene therapy kills prostate tumor cellsinnovations-report.com
- Biomarker testing is important to treat patients fighting cancer azcapitoltimes.com
- IMDC and Charité Researchers Identify Gene Responsible for Hypertension and Brachydactylyinnovations-report.com
- Local independent restaurants are fighting for survivallasvegasweekly.com
- Independent restaurants turn to crowdfunding for survivalocregister.com
- Brain tumor patients inspire blood, platelet drivebakersfield.com
- JTumor patients can receive financial aidjamestownpress.com
- Ultra-personal therapy: Gene tumor boards guide cancer carekentucky.com
- Study questions accuracy of certain tumor-only gene mappingThe Crescent-News
- Patients denied test for cancer geneBBC
- Gene therapy helps patients avoid blood transfusionCNN
- Recovered Corona patients share survival storiesThe Times of India
- Health startup helps patients become more independentThe Globe and Mail
- BBRCA gene mutation 'doesn't affect breast cancer survival'bbc.co.uk
- CGene discovery may explain female melanoma survival advantageclarencevalleynews.com.au
- Health Scan: Newly discovered gene affects melanoma survivalThe Jerusalem Post (JPost.com)
- Is Being Genius A Product Of Gene? | TV Independentindependent.ng